» Articles » PMID: 21661710

Treatment of Knee Osteoarthritis

Overview
Specialty Public Health
Date 2011 Jun 14
PMID 21661710
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Knee osteoarthritis is a common disabling condition that affects more than one-third of persons older than 65 years. Exercise, weight loss, physical therapy, intra-articular corticosteroid injections, and the use of nonsteroidal anti-inflammatory drugs and braces or heel wedges decrease pain and improve function. Acetaminophen, glucosamine, ginger, S-adenosylmethionine (SAM-e), capsaicin cream, topical nonsteroidal anti-inflammatory drugs, acupuncture, and tai chi may offer some benefit. Tramadol has a poor trade-off between risks and benefits and is not routinely recommended. Opioids are being used more often in patients with moderate to severe pain or diminished quality of life, but patients receiving these drugs must be carefully selected and monitored because of the inherent adverse effects. Intra-articular corticosteroid injections are effective, but evidence for injection of hyaluronic acid is mixed. Arthroscopic surgery has been shown to have no benefit in knee osteoarthritis. Total joint arthroplasty of the knee should be considered when conservative symptomatic management is ineffective.

Citing Articles

Synovial fluid dual-biomarker algorithm accurately differentiates osteoarthritis from inflammatory arthritis.

Keter D, Thai-Paquette V, Miamidian J, Gulati S, Toler K J Orthop Res. 2024; 43(2):304-310.

PMID: 39690934 PMC: 11701394. DOI: 10.1002/jor.26005.


Economic Evaluation of Total Knee Replacement Compared with Non-Surgical Management for Knee Osteoarthritis in India.

Qadeer A, Meher A, Rachel J, Paulson W, Patra A, Gandhi N Pharmacoecon Open. 2024; 9(2):217-229.

PMID: 39623243 PMC: 11865410. DOI: 10.1007/s41669-024-00541-3.


Addressing Knee Osteoarthritis Pathology Through Platelet-Rich Plasma Treatment: A Comprehensive Review.

Vlad S, Ghitea T, Manole F, Nutiu A, Lupsa A, Ghiurau N Adv Orthop. 2024; 2024:6551525.

PMID: 39606697 PMC: 11599444. DOI: 10.1155/2024/6551525.


The Outcomes at 3 Years in 82 Knees with Kellgren and Lawrence 2-3 Osteoarthritis Treated with an Autologous Protein Fluid Concentrate Produced with a Fluid Volume Reducer.

Sheinkop M, Langhenry M, Abd-Elsayed A Life (Basel). 2024; 14(10).

PMID: 39459640 PMC: 11509826. DOI: 10.3390/life14101340.


Exploring Platelet-Rich Plasma Therapy for Knee Osteoarthritis: An In-Depth Analysis.

Blaga F, Nutiu A, Lupsa A, Ghiurau N, Vlad S, Ghitea T J Funct Biomater. 2024; 15(8).

PMID: 39194659 PMC: 11355339. DOI: 10.3390/jfb15080221.